about
Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system.Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults.Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-γ and IL-17 production in blood from TB + patients from Honduras as compared to health care workers: TB and immune responses in patients from HondurasDysregulation of CD4+CD25(high) T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis.Treatment of new onset type 1 diabetes with teplizumab: successes and pitfalls in development.TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation.High content cellular immune profiling reveals differences between rhesus monkeys and men.Humanized mice as a model for aberrant responses in human T cell immunotherapy.Reduced IL-7 responsiveness defined by signal transducer and activator of transcription 5 phosphorylation in T cells may be a marker for increased risk of developing cytomegalovirus disease in patients after hematopoietic stem cell transplantation.Isolation and characterization of an immunogenic fragment of heat shock protein 60 from Trichophyton mentagrophytes.Tumor antigen-specific T-cells are Present in the CD8alphaalpha+ T-cell effector-memory pool.Interleukin-7 (IL-7) and IL-7 splice variants affect differentiation of human neural progenitor cells.Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer.A carbon nanotube-polymer composite for T-cell therapy.Alternative splicing of interleukin-7 (IL-7) and interleukin-7 receptor alpha (IL-7Rα) in peripheral blood from patients with multiple sclerosis (MS)Direct evidence of endothelial injury during cardiopulmonary bypass by demonstration of circulating endothelial cellsDelayed anti-CD3 therapy in a mouse heart transplant model induced tolerance and long-term survival of allograft: achieving tolerance
P50
Q33490992-32697768-4BB5-4121-9609-C1A60AF695C5Q33817588-000E9931-ADDA-4639-A922-3CC6F627FEBEQ34623344-A16B694F-E03F-4719-A468-4D2204F023D1Q36902069-2688A574-896D-4CD2-B3C6-4AB63C4E4510Q38187146-83453571-246D-403D-9286-CCEC08C1A725Q38958779-14957B02-0753-45C6-AB59-D516C628C255Q39873561-4C527F25-8988-4287-861D-0C41FC55772AQ41816196-53B15E62-72CC-43E0-B4B0-00EEB87B77B1Q42261265-CA6899E4-A0BF-485F-8E14-DC9674E7568FQ45188577-A0EE4173-1C8B-4BF3-B392-C15EC2FE0B4CQ46333671-2CA3EFC6-ED09-434D-A100-0603A96DD616Q48427721-1E5092FC-1E02-4325-B1DB-C455FDD49E84Q51974753-BB622192-9508-4316-B84C-811F933BF402Q53482969-A304106E-66C4-48F3-AE13-E81CEFEA06E7Q57209229-98DA6614-615C-434E-9D16-87DB9D47867EQ79830692-0F8455DA-C389-49C9-9F19-60411C0FE259Q86642638-5DC8031D-912E-445D-BA18-326F790677E8
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nalini Vudattu
@ast
Nalini Vudattu
@en
Nalini Vudattu
@es
Nalini Vudattu
@nl
Nalini Vudattu
@sl
type
label
Nalini Vudattu
@ast
Nalini Vudattu
@en
Nalini Vudattu
@es
Nalini Vudattu
@nl
Nalini Vudattu
@sl
prefLabel
Nalini Vudattu
@ast
Nalini Vudattu
@en
Nalini Vudattu
@es
Nalini Vudattu
@nl
Nalini Vudattu
@sl
P214
P906
P106
P214
P31
P496
0000-0001-6705-3332
P569
1974-01-01T00:00:00Z
P7859
viaf-86432018